KRT8 and ovarian carcinoma: In this study, we observed hypomethylation of m6A in KRT8 mRNA from ovarian cancer tissues, posttreatment with EZMLD led to a significant increase in m6A content in vivo and elevated m6A methylation of KRT8 mRNA in both in vitro and in vivo.